Use

The RAS/RAF Panel is an NGS-based assay designed to detect mutations across the full coding regions of key oncogenes—BRAF, HRAS, KRAS, and NRAS. It identifies mutations in the entire gene, including established hotspot regions in codons 12, 13, 59, 61, 117, and 146 as applicable, which can have important implications for diagnosis, prognosis, and therapeutic decisions in oncology, particularly in solid tumors where RAS/RAF pathway alterations drive tumor behavior.